Rapport Therapeutics, Inc. RAPP Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s total liabilities?
- Rapport Therapeutics, Inc. (RAPP) reported total liabilities of $26.09M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s total liabilities changed year-over-year?
- Rapport Therapeutics, Inc.'s total liabilities increased by 60.8% year-over-year, from $16.22M to $26.09M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s total liabilities?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s total liabilities has grown at a 38.5% compound annual growth rate (CAGR), from $14.48M to $27.78M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.